AEGLEA BIOTHERAPEUTICS INC stock forecast: up to 10.97 USD AGLE stock price prognosis


Forecast for Fri 17 Nov 2023 price 10.14

AEGLEA BIOTHERAPEUTICS INC stock price forecast for further price development up to 15.47% (time horizon: 1 day) and price target of 10.97 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) AEGLEA BIOTHERAPEUTICS INC share price prediction for 2023-11-17 with daily closed price projections

Key Facts

Symbol AGLE 

ISIN US00773J1034 

CUSIP 00773J103

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (0.70)

News <--> Close correlation for next day influence (-0.26)

Finance numbers

Revenue 0.0

Earnings per share -1.52

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

This strategy is focused on identifying misdiagnosed and undiagnosed patients. Topline data is expected from the trial in the fourth quarter of 2021. Metabolism refers to a network of life sustaining chemical reactions in the body. We are targeting Arginase 1 Deficiency with our lead product candidate, pegzilarginase. These patents will expire in 2029 in the absence of any patent term extension. A voucher may be awarded only for an approved rare pediatric disease product application. The reported data are posted in searchable form on a public website on an annual basis. Different pricing and reimbursement schemes exist in other countries. On November 10, 2020, oral arguments were heard in this case. It is unclear when a decision will be made. 25 ITEM 1A. RISK FACTORS Investing in our common stock involves a high degree of risk. We have not dosed any of our other product candidates in humans. As of December 31, 2020, we had an accumulated deficit of $276.0 million. We will need substantial additional funding. For example, the timing of our Phase 3 PEACE trial has been impacted by COVID-19. Any such shortages could cause us to delay or terminate our combination trials. We may not be successful in our efforts to identify additional product candidates. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty. In addition, the United States has recently enacted patent reform legislation. In such an event, this circumstance could have a material adverse effect on our business. Any of our management team members may terminate their employment with us at any time. We do not maintain "key person" insurance for any of our executives or other employees. It is possible that we may have triggered an "ownership change" limitation.

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 26.04/100
    • Not in ideal financial position.
    • Historical view, profit is not growing.
    • Company revenue is not growing faster compared with the industry.

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 99
MetLife Investment Management, LLC 2021-09-30 15353
MetLife Investment Management, LLC 2021-03-31 20285
MetLife Investment Management, LLC 2020-12-31 7990
MetLife Investment Management, LLC 2020-09-30 20131

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2023-02-28 34317 Long
Fidelity Concord Street Trust 2023-02-28 324238 Long
SUNAMERICA SERIES TRUST 2023-01-31 1300 Long
Fidelity Concord Street Trust 2023-05-31 125415 Long
Fidelity Concord Street Trust 2023-05-31 74199 Long

Bollinger Bollinger Bands for AEGLEA BIOTHERAPEUTICS INC can provide the information where the market is moving based on price information.

AEGLEA BIOTHERAPEUTICS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns AEGLEA BIOTHERAPEUTICS INC.

On-Balance Volume information for AEGLEA BIOTHERAPEUTICS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for AEGLEA BIOTHERAPEUTICS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for AEGLEA BIOTHERAPEUTICS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for AEGLEA BIOTHERAPEUTICS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for AEGLEA BIOTHERAPEUTICS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for AEGLEA BIOTHERAPEUTICS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for AEGLEA BIOTHERAPEUTICS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-10-19 10.97 2023-09-23 19:46
2023-10-09 11.15 2023-09-23 19:46
2023-10-10 11.14 2023-09-23 19:46
2023-10-20 10.70 2023-09-23 19:46
2023-10-11 11.15 2023-09-23 19:46
2023-09-26 12.75 2023-09-23 19:46
2023-09-25 12.35 2023-09-23 19:46
2023-10-05 11.10 2023-09-23 19:46
2023-09-28 11.53 2023-09-23 19:46
2023-09-27 10.82 2023-09-23 19:46
2023-10-26 10.63 2023-09-23 19:46
2023-11-02 10.45 2023-09-23 19:46
2023-10-02 11.70 2023-09-23 19:46
2023-10-03 11.52 2023-09-23 19:46
2023-11-08 10.32 2023-09-23 19:46
2023-11-03 10.43 2023-09-23 19:46
2023-10-12 11.13 2023-09-23 19:46
2023-11-10 10.27 2023-09-23 19:46
2023-10-27 10.60 2023-09-23 19:46
2023-10-04 11.26 2023-09-23 19:46
2023-10-13 10.91 2023-09-23 19:46
2023-10-23 10.62 2023-09-23 19:46
2023-10-24 10.76 2023-09-23 19:46
2023-11-09 10.30 2023-09-23 19:46
2023-09-29 12.27 2023-09-23 19:46
2023-10-06 11.22 2023-09-23 19:46
2023-11-13 10.27 2023-09-23 19:46
2023-11-14 10.22 2023-09-23 19:46
2023-10-25 10.69 2023-09-23 19:46
2023-11-06 10.42 2023-09-23 19:46
2023-11-07 10.36 2023-09-23 19:46
2023-10-16 10.92 2023-09-23 19:46
2023-10-17 10.93 2023-09-23 19:46
2023-10-18 10.90 2023-09-23 19:46
2023-11-15 10.16 2023-09-23 19:46
2023-10-30 10.54 2023-09-23 19:46
2023-10-31 10.53 2023-09-23 19:46
2023-11-01 10.50 2023-09-23 19:46
2023-11-16 10.16 2023-09-23 19:46
2023-11-17 10.14 2023-09-23 19:46

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.